0,940  0,001  Antimutagenic
0,907  0,002  NOS2 expression inhibitor
0,904  0,003  Chemopreventive
0,877  0,004  Caspase 9 stimulant
0,872  0,004  Cytostatic
0,838  0,011  Transcription factor NF kappa B inhibitor
0,822  0,004  UGT1A9 substrate
0,820  0,004  UGT1A6 substrate
0,827  0,014  Apoptosis agonist
0,788  0,003  UGT1A1 substrate
0,785  0,002  Melanin inhibitor
0,786  0,009  TNF expression inhibitor
0,775  0,005  Antioxidant
0,759  0,007  Chemoprotective
0,757  0,005  CTGF expression inhibitor
0,755  0,007  Mutagenic
0,750  0,014  Antineoplastic (breast cancer)
0,738  0,005  Proliferative diseases treatment
0,740  0,008  Radioprotector
0,739  0,011  Antineoplastic (colorectal cancer)
0,746  0,026  Alpha-glucosidase inhibitor
0,720  0,005  Free radical scavenger
0,714  0,005  Cardioprotectant
0,720  0,012  Antineoplastic (colon cancer)
0,711  0,004  Genotoxic
0,708  0,004  Monophenol monooxygenase inhibitor
0,709  0,005  Hypoglycemic
0,706  0,005  Antiamyloidogenic
0,709  0,017  Antineoplastic (lung cancer)
0,688  0,006  Antiparasitic
0,682  0,004  UGT1A3 substrate
0,681  0,004  Antihelmintic
0,682  0,009  CYP1A2 substrate
0,701  0,031  Antiinflammatory
0,688  0,019  CYP3A4 substrate
0,670  0,005  Hypoxia-inducible factor 1 alpha inhibitor
0,668  0,006  AR expression inhibitor
0,673  0,017  Antidiabetic
0,673  0,017  Cyclophilin D inhibitor
0,658  0,003  Amylase inhibitor
0,658  0,008  Cytotoxic
0,656  0,012  Antibacterial
0,656  0,018  Antileukemic
0,645  0,008  Caspase 3 stimulant
0,632  0,008  Histamine release inhibitor
0,636  0,018  CYP2C9 substrate
0,621  0,003  UGT2B15 substrate
0,622  0,006  UDP-glucuronosyltransferase substrate
0,621  0,007  CYP2C19 inhibitor
0,620  0,008  Antineoplastic (brain cancer)
0,612  0,012  Antineoplastic (cervical cancer)
0,602  0,003  Cystathionine beta-synthase inhibitor
0,602  0,005  Antihypoxic
0,603  0,008  Amyloid beta aggregation inhibitor
0,602  0,015  Antineoplastic (ovarian cancer)
0,595  0,011  NOS3 expression inhibitor
0,586  0,009  Antifungal
0,581  0,018  Carcinogenic
0,570  0,009  DNA damaging
0,572  0,011  Nitric oxide antagonist
0,573  0,021  Prostate cancer treatment
0,565  0,015  Antineoplastic (pancreatic cancer)
0,569  0,019  Antihypercholesterolemic
0,559  0,017  Antineoplastic (melanoma)
0,568  0,029  Alzheimer's disease treatment
0,544  0,008  RNA-directed DNA polymerase inhibitor
0,546  0,015  Apoptosis antagonist
0,531  0,009  Antihypertriglyceridemic
0,528  0,007  P-glycoprotein inhibitor
0,531  0,015  Antineoplastic (non-small cell lung cancer)
0,528  0,013  Antipyretic
0,532  0,025  Immunosuppressant
0,528  0,023  CYP2C19 substrate
0,504  0,003  Antiprotozoal (Coccidial)
0,501  0,004  Xanthine oxidase inhibitor
0,503  0,007  Hepatoprotectant
0,503  0,007  Skin whitener
0,515  0,019  Hepatic disorders treatment
0,517  0,021  Sensitization
0,511  0,017  Antineoplastic (glioma)
0,500  0,008  Antineoplastic (sarcoma)
0,496  0,007  Topoisomerase II inhibitor
0,495  0,012  Antineoplastic enhancer
0,485  0,003  Antihemorrhagic
0,493  0,017  Antiprotozoal (Leishmania)
0,491  0,015  Antineoplastic (glioblastoma multiforme)
0,484  0,014  Antimitotic
0,498  0,033  Aldehyde oxidase inhibitor
0,482  0,018  Vasodilator, coronary
0,468  0,007  Antihypotensive
0,461  0,008  Interferon gamma antagonist
0,455  0,006  Alkylator
0,461  0,014  Antineoplastic (osteosarcoma)
0,483  0,038  Antipruritic, allergic
0,471  0,030  CYP2D6 substrate
0,432  0,005  Antineoplastic antibiotic
0,463  0,035  Antithrombotic
0,446  0,019  Antineoplastic (lymphoma)
0,444  0,021  UGT2B4 substrate
0,431  0,009  Antineoplastic (squamous cell carcinoma)
0,482  0,062  Antineoplastic (solid tumors)
0,424  0,007  NOS3 expression enhancer
0,430  0,018  Vascular (periferal) disease treatment
0,430  0,017  Angiogenesis stimulant
0,430  0,018  Antineoplastic (liver cancer)
0,437  0,027  ICAM1 expression inhibitor
0,405  0,004  AMP-activated protein kinase stimulant
0,407  0,009  VCAM1 expression inhibitor
0,431  0,039  Respiratory analeptic
0,405  0,024  Antidiabetic symptomatic
0,386  0,009  Protein kinase stimulant
0,389  0,012  UGT2B7 substrate
0,390  0,016  UGT1A4 substrate
0,396  0,024  Vasodilator
0,380  0,014  Antineoplastic (carcinoma)
0,370  0,005  Interleukin 4 antagonist
0,426  0,063  15-Lipoxygenase inhibitor
0,368  0,005  Topoisomerase II alpha inhibitor
0,370  0,008  Sulfotransferase substrate
0,385  0,027  Antineoplastic (renal cancer)
0,377  0,024  Antineoplastic (small cell lung cancer)
0,355  0,007  Antifungal enhancer
0,354  0,008  Insulin secretagoues
0,400  0,059  Ulceration
0,356  0,017  Antiviral (Influenza)
0,380  0,043  Lipoxygenase inhibitor
0,379  0,045  Spasmolytic
0,367  0,034  Tumour necrosis factor alpha release inhibitor
0,391  0,060  Stroke treatment
0,340  0,012  Antiviral (Influenza A)
0,339  0,014  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,371  0,048  Teratogen
0,345  0,025  Antineoplastic (bladder cancer)
0,326  0,009  Cholesterol synthesis inhibitor
0,322  0,005  Beta glucuronidase inhibitor
0,318  0,005  ATPase inhibitor
0,318  0,007  Expectorant
0,317  0,008  Nitric-oxide synthase stimulant
0,336  0,033  DNA synthesis inhibitor
0,325  0,026  Platelet adhesion inhibitor
0,313  0,020  Peptidyltransferase inhibitor
0,336  0,047  Antineoplastic (multiple myeloma)
0,306  0,017  Antineoplastic (gastric cancer)
0,297  0,011  Topoisomerase I inhibitor
0,304  0,018  Lipid peroxidase inhibitor
0,298  0,013  NADPH oxidase inhibitor
0,332  0,049  Antidiabetic (type 2)
0,292  0,010  SULT1A3 substrate
0,300  0,019  Tubulin antagonist
0,301  0,027  DNA methylase inhibitor
0,288  0,016  Interleukin 6 antagonist
0,318  0,049  Radiosensitizer
0,267  0,005  NAD(P)H dehydrogenase (quinone) inhibitor
0,277  0,016  Acetylcholinesterase inhibitor
0,277  0,018  Antidote
0,315  0,058  Antineoplastic (endocrine cancer)
0,282  0,026  Antiviral (Herpes)
0,268  0,017  Antineoplastic (bone cancer)
0,282  0,033  DNA methyltransferase I inhibitor
0,310  0,062  Antiosteoporotic
0,357  0,109  5 Hydroxytryptamine release inhibitor
0,321  0,077  Bone diseases treatment
0,290  0,046  Antiulcerative
0,290  0,047  Antineoplastic (lymphocytic leukemia)
0,254  0,012  VEGF expression inhibitor
0,300  0,059  Embryotoxic
0,312  0,071  CYP3A4 inhibitor
0,309  0,070  Analeptic
0,263  0,027  Protein-tyrosine phosphatase inhibitor
0,239  0,006  Electron transport complex I inhibitor
0,242  0,009  Beta amyloid protein antagonist
0,333  0,101  Antiprotozoal
0,237  0,006  Antineoplastic (uterine cancer)
0,235  0,005  Multidrug resistance-associated protein 1 inhibitor
0,289  0,061  Antiprotozoal (Trypanosoma)
0,281  0,056  5 Hydroxytryptamine uptake stimulant
0,241  0,019  Aldose reductase substrate
0,300  0,078  Immunostimulant
0,233  0,011  Carbonic anhydrase III inhibitor
0,225  0,006  Aldose reductase inhibitor
0,228  0,010  Carbonic anhydrase XIII inhibitor
0,231  0,013  Microtubule formation inhibitor
0,271  0,054  Cyclic AMP phosphodiesterase inhibitor
0,225  0,008  Gastritis treatment
0,280  0,068  CYP1A2 inhibitor
0,227  0,016  Antirickettsial
0,225  0,022  Glutathione S-transferase substrate
0,211  0,009  Creatine kinase inhibitor
0,296  0,094  Cholesterol antagonist
0,221  0,020  Antitussive
0,309  0,109  CYP2C9 inhibitor
0,217  0,021  DNA intercalator
0,231  0,037  Diabetic nephropathy treatment
0,217  0,024  Protein-tyrosine phosphatase 1B inhibitor
0,207  0,016  Cyclooxygenase 3 inhibitor
0,203  0,013  Mucolytic
0,216  0,027  UGT2B10 substrate
0,236  0,047  Neurotrophic factor enhancer
0,200  0,013  Uric acid excretion stimulant
0,192  0,010  DNA repair enzyme inhibitor
0,275  0,095  12-Lipoxygenase inhibitor
0,251  0,072  Platelet antagonist
0,192  0,014  Antibiotic
0,192  0,014  Dementia treatment
0,216  0,040  Cholinergic
0,195  0,020  SULT1A1 substrate
0,190  0,015  Breast cancer-resistant protein inhibitor
0,187  0,014  Vascular dementia treatment
0,207  0,036  UGT2B9 substrate
0,267  0,097  Antimycobacterial
0,255  0,091  GST M1-1 substrate
0,186  0,022  Antihelmintic (Trematoda)
0,209  0,047  LDLR expression enhancer
0,167  0,012  HIV-1 integrase (3'-Processing) inhibitor
0,171  0,017  Estrogen antagonist
0,163  0,012  Aromatase inhibitor
0,169  0,021  Papain-like protease (SARS coronavirus) inhibitor
0,184  0,038  M18 aspartyl aminopeptidase inhibitor
0,157  0,012  HIV-1 integrase (Strand Transfer) inhibitor
0,208  0,065  Insulin sensitizer
0,207  0,068  Pneumotoxic
0,155  0,017  Selectin antagonist
0,180  0,042  Alkaline phosphatase inhibitor
0,161  0,025  UGT2B1 substrate
0,150  0,015  Estrogen receptor beta antagonist
0,220  0,092  Myocardial infarction treatment
0,153  0,026  Antiviral (Influenza B)
0,175  0,049  Antidiarrheal
0,191  0,067  Antiviral (Hepatitis)
0,134  0,012  ATPase (Vacuolar H+) inhibitor
0,140  0,021  Antiviral (Coronavirus)
0,140  0,021  Antiviral (SARS coronavirus)
0,126  0,007  Antimycoplasmal
0,133  0,015  Estrogen receptor alpha antagonist
0,224  0,108  Transcription factor STAT inhibitor
0,158  0,043  Aldehyde dehydrogenase inhibitor
0,203  0,089  Cardiodepressant
0,251  0,139  Antiprotozoal (Plasmodium)
0,133  0,022  SULT1E1 substrate
0,140  0,031  Chronic obstructive bronchitis treatment
0,144  0,037  Chelator
0,176  0,070  Dual specificity phosphatase inhibitor
0,121  0,016  Na+ K+ transporting ATPase inhibitor
0,191  0,086  Pyruvate kinase inhibitor
0,112  0,009  Antitreponemal
0,146  0,044  Growth stimulant
0,150  0,049  DNA polymerase I inhibitor
0,125  0,028  Carbonic anhydrase VI inhibitor
0,147  0,051  Ca2+-transporting ATPase inhibitor
0,138  0,043  5-Lipoxygenase inhibitor
0,110  0,015  Estrogen agonist
0,102  0,009  Topoisomerase II beta inhibitor
0,148  0,056  Carcinogenic, group 3
0,164  0,073  Antihelmintic (Nematodes)
0,136  0,046  Carcinogenic, group 2B
0,120  0,030  Thioredoxin inhibitor
0,110  0,021  Thioredoxin reductase inhibitor
0,101  0,013  Protein 50S ribosomal subunit inhibitor
0,121  0,034  UGT2B11 substrate
0,094  0,008  Transcription factor RelA inhibitor
0,148  0,065  Adenylate cyclase stimulant
0,146  0,064  Antifungal (Cryptococcus)
0,094  0,012  Estrogen receptor beta agonist
0,102  0,023  T cell inhibitor
0,093  0,016  Alpha tubulin antagonist
0,094  0,018  Postmenopausal disorders treatment
0,142  0,068  Contraceptive
0,151  0,077  Peroxidase inhibitor
0,078  0,004  Sodium/glucose cotransporter 2 inhibitor
0,170  0,098  CYP2B6 inhibitor
0,089  0,020  Neuraminidase inhibitor
0,140  0,073  Heat shock protein 70 antagonist
0,134  0,067  Cyclooxygenase 1 inhibitor
0,087  0,021  Neuraminidase (influenza) inhibitor
0,102  0,037  Antiviral (Trachoma)
0,079  0,014  Postcoital contraceptive
0,127  0,063  Antiviral (Hepatitis B)
0,151  0,087  Arachidonic acid antagonist
0,135  0,075  Neurotrophic factor
0,074  0,014  Glucose-6-phosphate translocase inhibitor
0,231  0,172  GABA C receptor rho-3 antagonist
0,085  0,027  Beta tubulin antagonist
0,115  0,057  Choleretic
0,113  0,056  MAO A inhibitor
0,080  0,024  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,097  0,042  Antiviral (Hepatitis A)
0,058  0,004  Sodium/glucose cotransporter inhibitor
0,140  0,087  GABA C receptor rho-2 antagonist
0,106  0,054  UDP-glucose 4-epimerase inhibitor
0,063  0,011  Microtubule stabilization
0,088  0,036  CDC25A inhibitor
0,160  0,111  Interleukin antagonist
0,122  0,073  MAO inhibitor
0,086  0,037  Lipase inhibitor
0,100  0,052  Alcohol dehydrogenase inhibitor
0,129  0,082  Psychosexual dysfunction treatment
0,146  0,101  Antipruritic, non-allergic
0,091  0,049  Transcription factor NF kappa B stimulant
0,105  0,063  Gout treatment
0,057  0,015  Neuraminidase (Influenza A) inhibitor
0,248  0,207  Calcium channel L-type activator
0,063  0,022  Antibiotic Glycopeptide-like
0,143  0,102  Dual specificity phosphatase 3 inhibitor
0,078  0,040  HIV-1 integrase inhibitor
0,066  0,029  Fatty acid synthase inhibitor
0,088  0,051  mTOR complex 2 inhibitor
0,046  0,009  ATP citrate lysase inhibitor
0,097  0,059  Interleukin 12 antagonist
0,041  0,005  Sodium/glucose cotransporter 1 inhibitor
0,046  0,010  Tubulin agonist
0,078  0,044  Histidine decarboxylase inhibitor
0,143  0,109  Tumour necrosis factor antagonist
0,074  0,040  Anticholelithogenic
0,091  0,058  Aminoacyl-tRNA synthetase inhibitor
0,090  0,058  Actinic keratosis treatment
0,046  0,016  Antibiotic Aminoglycoside-like
0,047  0,018  Estrogen receptor alpha agonist
0,036  0,006  Dopamine D1 agonist
0,158  0,129  Aryl hydrocarbon receptor agonist
0,096  0,068  Anabolic
0,030  0,004  Antibiotic Anthracycline-like
0,074  0,049  Telomerase inhibitor
0,173  0,148  Lipoprotein disorders treatment
0,120  0,099  Cyclooxygenase inhibitor
0,084  0,064  Interleukin 5 antagonist
0,110  0,091  Cyclooxygenase 2 inhibitor
0,171  0,152  5 Hydroxytryptamine release stimulant
0,095  0,078  Toll-Like receptor 4 antagonist
0,118  0,102  Cell wall synthesis inhibitor
0,171  0,155  Superoxide dismutase inhibitor
0,215  0,200  Antineoplastic (non-Hodgkin's lymphoma)
0,056  0,042  Xanthine dehydrogenase inhibitor
0,081  0,067  Ornithine decarboxylase inhibitor
0,027  0,014  Protein 30S ribosomal subunit inhibitor
0,092  0,080  Mediator release inhibitor
0,125  0,113  Antinephritic
0,086  0,075  Butyrylcholinesterase inhibitor
0,032  0,022  Nucleoside transporters inhibitor
0,190  0,181  Angiogenesis inhibitor
0,055  0,049  Lipocortins synthesis agonist
0,042  0,038  Carbonic anhydrase VII inhibitor
0,030  0,028  Estrogen-related receptor beta antagonist
0,013  0,011  Antibiotic Macrolide-like

